featured
Prophylactic Minocycline for Erlotinib-Induced Skin Toxicities
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer
J. Clin. Oncol 2015 Nov 16;[EPub Ahead of Print], B Melosky, H Anderson, RL Burkes, Q Chu, D Hao, V Ho, C Ho, W Lam, CW Lee, NB Leighl, N Murray, S Sun, R Winston, JJ LaskinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.